Potential Cancer Risk from Tacrolimus Ointment
Author Information
Author(s): Becker Jürgen C, Houben Roland, Vetter Claudia S, Bröcker Eva B
Primary Institution: Department of Dermatology, Julius-Maximilians-University, Würzburg, Germany
Hypothesis
The carcinogenic potential of tacrolimus may go beyond mere immune suppression.
Conclusion
The study suggests a possible link between the use of tacrolimus and the development of squamous cell carcinoma.
Supporting Evidence
- Tacrolimus ointment is used for various inflammatory skin diseases.
- The FDA has warned about a potential cancer risk associated with tacrolimus.
- The patient developed squamous cell carcinoma after prolonged use of tacrolimus.
Takeaway
Using tacrolimus ointment might increase the risk of getting cancer, not just because it weakens the immune system, but also for other reasons.
Methodology
Case report of a patient treated with tacrolimus ointment for oral lichen planus who later developed squamous cell carcinoma.
Potential Biases
Potential bias due to the nature of a case report and lack of control group.
Limitations
The study is based on a single case report, which limits the generalizability of the findings.
Participant Demographics
One 56-year-old female patient.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website